• Advanced gene delivery system secures Japan patent

Company News

Advanced gene delivery system secures Japan patent

Jan 17 2024

ProBioGen has announced that the Japan Patent Office (JPO) has granted the first patent for the company’s DirectedLuck® technology. This advanced gene delivery system is anchored in a highly potent transposase fusion variant, facilitating epigenetic targeting alongside a meticulously designed transposon.

Dr Volker Sandig, Chief Scientific Officer of ProBioGen, emphasised the significance of this patent grant for the ground-breaking cell-engineering technology. The plug-and-play system offers advantages throughout the biopharmaceutical value chain, enabling accelerated timelines for clinical applications. Dr Sandig stated: ‘‘Thanks to our DirectedLuck® technology, clients attain higher titres and maximum stability within condensed timelines.’’

ProBioGen has successfully implemented DirectedLuck® to generate numerous producer cell lines for clients, garnering endorsement from ProBioGen’s licensees. Beyond its application in generating producer cell lines, DirectedLuck® proves versatile for creating stable packaging cell lines for viral vectors and finds utility in gene and cell therapy.

More information online


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

Interphex

Apr 16 2024 New York, USA

Medtec Japan 2024

Apr 17 2024 Tokyo, Japan

FORUMESURE

Apr 22 2024 Marrakech, Morroco

View all events